| 0.97 -0.007 (-0.67%) | 07-28 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.26 | 1-year : | 1.47 |
| Resists | First : | 1.08 | Second : | 1.26 |
| Pivot price | 0.99 | |||
| Supports | First : | 0.9 | Second : | 0.79 |
| MAs | MA(5) : | 0.99  |
MA(20) : | 0.98 |
| MA(100) : | 1.05 |
MA(250) : | 1.82 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 40.1 |
D(3) : | 46.6 |
| RSI | RSI(14): 50.1 |
|||
| 52-week | High : | 5.55 | Low : | 0.68 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ LITS ] has closed above bottom band by 24.7%. Bollinger Bands are 59.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.99 - 1 | 1 - 1 |
| Low: | 0.94 - 0.95 | 0.95 - 0.96 |
| Close: | 0.96 - 0.97 | 0.97 - 0.98 |
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Mon, 27 Jul 2026
LITS|Lite Strategy Ord Shs|Price:0.981|Chg%:-0.007 - TradingKey
Fri, 24 Jul 2026
Lite Strategy readies investor deck, discloses 830,378 LTC treasury, $25M buyback plan - TradingView
Fri, 17 Jul 2026
MSN Money - MSN
Fri, 19 Jun 2026
Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam - GlobeNewswire
Fri, 19 Jun 2026
Lite Strategy, Inc. to Join Litecoin Foundation Summit Panel on Litecoin’s Institutional Opportunity - Quiver Quantitative
Thu, 18 Jun 2026
Lite Strategy invests $1M in Litecoin layer 2 developer By Investing.com - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 34 (M) |
| Shares Float | 26 (M) |
| Held by Insiders | 11.9 (%) |
| Held by Institutions | 17.3 (%) |
| Shares Short | 118 (K) |
| Shares Short P.Month | 97 (K) |
| EPS | -2.08 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.62 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -27.7 % |
| Return on Equity (ttm) | -159.3 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | -0.06 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.51 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -10 (M) |
| Levered Free Cash Flow | -13 (M) |
| PE Ratio | -0.47 |
| PEG Ratio | 2.2 |
| Price to Book value | 0.59 |
| Price to Sales | 0 |
| Price to Cash Flow | -3.17 |
| Dividend | 1.75 |
| Forward Dividend | 0 |
| Dividend Yield | 180.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|